However, since this method suppressed the early neuronal processes, including neuronal proliferation, the AAV-NT3 therapy may negatively regulate the hippocampal neurogenesis in long-run, which can prove detrimental in the progression of neurodegenerative diseases like AD (Kasakura et al., 2023). The gene discussed is NTF3; the disease is Alzheimer disease.